Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Surg Res. 2020 Mar 12;251:228–238. doi: 10.1016/j.jss.2020.01.008

Table 2 -.

ROC analysis for RPS, TS, and all patients in the cohort for both NLR and PLR.

Biomarker Tumor location Outcome Binary cutoff* AUC Sensitivity (%) Specificity (%)
NLR All RFS 0.97 0.58 58 54
OS 1.08 0.47 49 50
RPS RFS 1.24 0.55 54 53
OS 1.31 0.55 55 55
TS RFS 0.81 0.60 56 57
OS 0.84 0.37 41 41
PLR All RFS 50.9 0.59 64 51
OS 65.5 0.49 54 46
RPS RFS 67.5 0.56 56 54
OS 74.2 0.56 56 56
TS RFS 44.2 0.60 58 57
OS 44.5 0.41 46 45
*

Determined by Youden index.